Display options
Share it on

Exp Ther Med. 2017 Jun;13(6):3075-3080. doi: 10.3892/etm.2017.4332. Epub 2017 Apr 12.

Effect of VBC-1814/7J, a poly-phytocompound, on a non-infectious model of pharyngitis.

Experimental and therapeutic medicine

Junji Uemura, Ravinder Nagpal, Nicola Zerbinati, Birbal Singh, Massimiliano Marcellino, Dheeraj Mohania, Francesco Marotta, Fang He, Antonio Ayala, Yasuhiro Kasugai, Roberto Catanzaro

Affiliations

  1. Suheiro Chem-Tech Center, Niigata 950-1447, Japan.
  2. Division of Laboratories for Probiotic Research, Juntendo University Graduate School of Medicine, Tokyo 162-0803, Japan.
  3. CMP-Medical Center and Laboratories, I-27100 Pavia, Italy.
  4. Indian Veterinary Research Institute, Regional Station, Palampur, Himachal Pradesh 176061, India.
  5. ReGenera Research Group for Aging Intervention, I-20154 Milan, Italy.
  6. Animal Biochemistry Division, National Dairy Research Institute, Karnal, Haryana 121001, India.
  7. Department of Nutrition and Food Hygiene, West China School of Public Health, Sichuan University, Chengdu, Sichuan 610000, P.R. China.
  8. Department of Biochemistry and Molecular Biology, Seville University, I-41000 Seville, Spain.
  9. Department of Internal Medicine, University of Catania, 95121 Catania, Italy.

PMID: 28587382 PMCID: PMC5450604 DOI: 10.3892/etm.2017.4332

Abstract

Pharyngitis presents as an inflammation of the oropharynx, and clinical examination often shows evidence of nasopharyngitis. In numerous cases the condition occurs as a self-limiting illness of non-infectious aetiology, whose clinical management remains a matter for debate given the inappropriateness of antibiotics, the reported worsening following steroid use and the recent discouragement of the use of Chinese herbal medicine. The aim of the present study was thus to test VBC-1814/7J, a poly-phytocompound with known anti-inflammatory and immune-response enhancing properties, in an experimental model of non-infectious pharyngitis. Experimental non-infectious pharyngitis was induced by applying a pyridine solution to the surface of the pharyngeal mucosa in rats that were either normally fed (group A) or fed VBC-1814/7J three days prior to and three days subsequent to the induction of pharyngitis (group B). Healthy rats treated with topical saline were used as a control (group C). At time-points of 0, one hour, one day and three days sacrifices were carried out and microscopic examination, Evans blue (EB) dye extravasation and tissue concentrations of tumour necrosis factor (TNF)-α, interleukin (IL)-6 and mRNA of α- and β-defensins were studied. As compared with group C, group A showed significant microscopic damage, EB extravasation, and increases in the levels of TNF-α and IL-6, as well as in the mRNA of three defensins (P<0.001) on the third day of observation. VBC-1814/7J significantly mitigated these microscopic and inflammatory markers while allowing a prompter and wider defensin reaction (P<0.05 vs. group A). These data suggest that VBC-1814/7J, as demonstrated in earlier studies, has the potential to address non-infectious pharyngitis in clinical practice.

Keywords: non-infectious model of pharyngitis; phytocompound; β-defensins

References

  1. Proc Am Thorac Soc. 2011 Mar;8(1):106-14 - PubMed
  2. Indoor Air. 2000 Dec;10(4):246-57 - PubMed
  3. Zhongguo Dang Dai Er Ke Za Zhi. 2012 Jun;14(6):431-3 - PubMed
  4. Curr Allergy Asthma Rep. 2010 Mar;10(2):77-83 - PubMed
  5. Pharm Biol. 2015 Apr;53(4):533-9 - PubMed
  6. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):597-600 - PubMed
  7. Occup Environ Med. 2002 Jan;59(1):18-22 - PubMed
  8. Clin Otolaryngol. 2008 Dec;33(6):581-6 - PubMed
  9. Clin Otolaryngol Allied Sci. 1986 Oct;11(5):317-21 - PubMed
  10. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004877 - PubMed
  11. Indoor Air. 2008 Aug;18(4):301-16 - PubMed
  12. J Occup Environ Med. 2005 Jul;47(7):698-703 - PubMed
  13. Int J Tuberc Lung Dis. 2010 Sep;14(9):1079-86 - PubMed
  14. Int J Clin Pharmacol Res. 1986;6(1):81-6 - PubMed
  15. J Int Med Res. 1988 Nov-Dec;16(6):466-73 - PubMed
  16. Curr Opin Hematol. 2014 Jan;21(1):37-42 - PubMed
  17. Respir Med. 2009 Mar;103(3):456-62 - PubMed
  18. Respir Physiol Neurobiol. 2008 Jan 1;160(1):37-44 - PubMed
  19. Br J Gen Pract. 2000 Oct;50(459):817-20 - PubMed
  20. Arch Environ Health. 2004 Dec;59(12):669-76 - PubMed
  21. J Occup Environ Med. 2003 Jun;45(6):622-7 - PubMed
  22. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD000023 - PubMed
  23. Appl Occup Environ Hyg. 2001 Oct;16(10):952-60 - PubMed
  24. Biomed Khim. 2014 Jul-Aug;60(4):438-47 - PubMed
  25. Ann Allergy Asthma Immunol. 2013 Mar;110(3):178-83 - PubMed
  26. Sci Rep. 2014 Oct 10;4:6588 - PubMed
  27. Compr Physiol. 2014 Jan;4(1):287-324 - PubMed
  28. Nat Prod Res. 2014;28(16):1246-53 - PubMed
  29. Occup Med (Lond). 2002 Mar;52(2):99-101 - PubMed
  30. J Pharmacol Toxicol Methods. 2014 Mar-Apr;69(2):189-95 - PubMed
  31. J Voice. 2010 Sep;24(5):599-605 - PubMed
  32. Neurotoxicology. 2001 Dec;22(6):795-810 - PubMed
  33. J Voice. 1998 Jun;12(2):197-207 - PubMed

Publication Types